Skip to main content

PLx Pharma Winddown Corp.

PLXPDelisted May 2, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001497504

PLx Pharma Winddown Corp. was delisted on May 2, 2023; its insiders filed their last Form 4 on Mar 16, 2022; 35 institutions reported holding it in 13F filings for Q1 2023, worth $477.6K in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by PLx Pharma Winddown Corp. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for PLx Pharma Winddown Corp., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for PLx Pharma Winddown Corp.
NameTitleLast reported holdingLast filingFilings, past year
Giordano NatashaChief Executive Officer5,186Mar 16, 20220
O'Connor Rita MChief Financial Officer26,670Mar 16, 20220
Calhoun Kirk KDirector–Feb 24, 20220
Hadden JohnDirector–Feb 24, 20220
Valentino Michael JExecutive Chairman–Feb 24, 20220
Balkema Gary S.Director–Feb 24, 20220
Casale RobertDirector–Feb 24, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 16, 2022 (view filing)Mar 151 dayGiordano NatashaChief Executive OfficerPPurchase+4.10K$3.65+$15.0K+377.5%5.19K after
Mar 16, 2022 (view filing)Mar 151 dayO'Connor Rita MChief Financial OfficerPPurchase+13.7K$3.66+$50.1K+105.6%26.7K after2 lots